
Novo Nordisk Advances Wegovy with First Oral GLP-1 Weight Loss Treatment Targeting Obesity Management
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
In this episode, we dive into Novo Nordisk's groundbreaking advancement with Wegovy, as they make significant progress toward developing the first-ever oral GLP-1 weight loss medication. The FDA has recently accepted Novo Nordisk's New Drug Application for an oral formulation of their popular weight loss treatment, potentially revolutionizing obesity management.
We explore how this once-daily pill could transform treatment options for patients currently using injectable Wegovy, with clinical trials showing impressive 13.6% average weight loss. The episode also covers Wegovy's expanded medical applications, including its historic FDA approval for reducing cardiovascular risks, positive news about resolved supply shortages, and ongoing research into additional benefits for liver disease and dementia prevention.
Perfect for healthcare professionals, patients considering weight loss treatments, or anyone interested in pharmaceutical innovations, this episode provides comprehensive insights into the evolving landscape of obesity management and what this potential game-changing oral medication could mean for millions of people worldwide.
#WeightLossBreakthrough #OralGLP1 #ObesityTreatment #NovoNordisk #Wegovy #PharmaceuticalInnovation #WeightManagement
activate_mytile_page_redirect_t1
What listeners say about Novo Nordisk Advances Wegovy with First Oral GLP-1 Weight Loss Treatment Targeting Obesity Management
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.